203 related articles for article (PubMed ID: 36925023)
1. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
Huang Y; Li C; Zhang X; Zhang M; Ma Y; Qin D; Tang S; Fei W; Qin J
Int J Pharm; 2023 Apr; 636():122827. PubMed ID: 36925023
[TBL] [Abstract][Full Text] [Related]
2. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Xiang DX
J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
[TBL] [Abstract][Full Text] [Related]
3. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.
Rhoda K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2015 Apr; 12(4):613-34. PubMed ID: 25300775
[TBL] [Abstract][Full Text] [Related]
4. Targeting Tumour Metastasis: The Emerging Role of Nanotechnology.
Visentin S; Sedić M; Pavelić SK; Pavelić K
Curr Med Chem; 2020; 27(8):1367-1381. PubMed ID: 30569844
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted.
Gupta S; Pathak Y; Gupta MK; Vyas SP
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4066-4088. PubMed ID: 31625408
[TBL] [Abstract][Full Text] [Related]
6. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.
Yousefi M; Dehghani S; Nosrati R; Ghanei M; Salmaninejad A; Rajaie S; Hasanzadeh M; Pasdar A
Cell Oncol (Dordr); 2020 Aug; 43(4):515-538. PubMed ID: 32418122
[TBL] [Abstract][Full Text] [Related]
7. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70
Ma J; Kala S; Yung S; Chan TM; Cao Y; Jiang Y; Liu X; Giorgio S; Peng L; Wong AST
Mol Ther; 2018 Jan; 26(1):70-83. PubMed ID: 29241971
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract][Full Text] [Related]
9. Cancer bone metastases and nanotechnology-based treatment strategies.
Li Z; Zhang W; Zhang Z; Gao H; Qin Y
Expert Opin Drug Deliv; 2022 Oct; 19(10):1217-1232. PubMed ID: 35737871
[TBL] [Abstract][Full Text] [Related]
10. The potentials of nanotechnology-based drug delivery system for treatment of ovarian cancer.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2015; 43(4):291-7. PubMed ID: 24245788
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
12. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract][Full Text] [Related]
14. Emerging targeted drug delivery strategies toward ovarian cancer.
Wang Z; Meng F; Zhong Z
Adv Drug Deliv Rev; 2021 Nov; 178():113969. PubMed ID: 34509574
[TBL] [Abstract][Full Text] [Related]
15. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
16. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
17. Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature.
Subhan A; Attia SA; P Torchilin V
Nanomedicine (Lond); 2022 Jan; 17(1):41-64. PubMed ID: 34930021
[TBL] [Abstract][Full Text] [Related]
18. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.
Hoosen Y; Pradeep P; Kumar P; du Toit LC; Choonara YE; Pillay V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510526
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-aided advancement in the combating of cancer metastasis.
Avula LR; Grodzinski P
Cancer Metastasis Rev; 2022 Jun; 41(2):383-404. PubMed ID: 35366154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
